Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

YAP ‐ TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape

FEBS Open Bio(2024)10.1002/2211-5463.13901Source: DataRank Database

YAP ‐ TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape is a research paper published in FEBS Open Bio (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

cellosaurus pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.15)OA: goldTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Ryan Watkins ORCID,Jennifer L. Tomlinson ORCID,Jennifer A. Yonkus ORCID,Amro M. Abdelrahman ORCID,Caitlin B. Conboy ORCID

Live enrichment

PubMed:39300603 PMC:PMC11532981 OpenAlex:https://openalex.org/W4402695207

Center for Cell Signaling in Gastroenterology, Mayo Clinic

Grant: P30DK084567

NCI NIH HHS

Grant: P50 CA210964

NCI NIH HHS

Grant: P30 CA015083

NCI (NIH)

Grant: 5P30 CA15083-43C1

Fulbright Foundation in the United States

FWCI

1.15

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/2211-5463.13901

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/2211-5463.13901

publisherhttps://febs.onlinelibrary.wiley.com/doi/pdf/10.1002/2211-5463.13901

journalhttps://doi.org/10.1002/2211-5463.13901

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39300603

Fields of Study

Hippo pathway signaling and YAP/TAZCholangiocarcinoma and Gallbladder Cancer StudiesCancer-related gene regulation

MeSH Terms

YAP-Signaling ProteinsTEA Domain Transcription FactorsAnimalsHumansReceptors, AndrogenTranscription FactorsUp-RegulationGene Expression Regulation, NeoplasticXenograft Model Antitumor AssaysCell Line, TumorAdaptor Proteins, Signal TransducingMice

Keywords

Downregulation and upregulationAndrogen receptorBiologyCancer researchTranscription factorSignal transductionHippo signaling pathwayCell growthCancerAndrogenReceptorCell biologyGeneEndocrinologyGeneticsProstate cancerBile Duct TumorsHippo PathwayEnzalutamideFibroblast Growth Factor Receptor

Sustainable Development Goals

SDG 0: Good health and well-being

YAP ‐ TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape

FAIR Checklist

Authors (14)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)